PsychiatryNews.net

Psychiatry Xagena

Search results for "Atypical antipsychotics"

The U.S. FDA ( Food and Drug Administration ) approved Aripiprazole ( Abilify ) for maintaining efficacy in patients with bipolar I disorder with a recent manic or mixed episode who had been stabilize ...


The FDA ( Food and Drug Administration ) issued a public health advisory to alert health care providers, patients, and patient caregivers to new safety information concerning an unapproved ( i.e., “o ...


In two double-blind, randomized, multicenter studies evaluated the investigational use of intramuscular ( IM ) Aripiprazole ( Abilify ) in patients with either acute bipolar mania or schizophrenia. ...


A head-to- head study comparing Olanzapine and Fluoxetine capsules ( OFC ) and Lamotrigine for the treatment of bipolar depression, showed that patients treated with OFC experienced significantly gre ...


A study showed Seroquel’s efficacy in reducing aggression and violent behaviour in patients with psychotic schizophrenia symptoms. The study was published in journal Human Psychopharmacology: Clini ...


A large study, Clinical Antipsychotic Trials of Intervention Effectiveness ( CATIE ), funded by NIH's National Institute of Mental Health ( NIMH ) provides, for the first time, detailed information co ...


Atypical antipsychotics have benefits for psychiatric illness in children and adolescents but are often accompanied by significant weight gain, possibly resulting in type 2 diabetes. Metformin ( Gl ...


Saphris ( Asenapine ) is a psychotropic agent indicated for acute treatment of schizophrenia in adults and acute treatment of manic or mixed episodes associated with bipolar I disorder with or without ...


Risperidone ( Risperdal ) is an atypical antipsychotic agent indicated for the treatment or management of schizophrenia, inappropriate behaviour associated with severe dementia and manic episodes asso ...